Efficacy and safety of regorafenib in Japanese patients with advanced gastrointestinal stromal tumors.
Ryugo TeranishiTsuyoshi TakahashiToshirou NishidaSeiichi HirotaYukinori KurokawaTakuro SaitoKazuyoshi YamamotoKotaro YamashitaKoji TanakaTomoki MakinoMasaaki MotooriTakeshi OmoriKiyokazu NakajimaHidetoshi EguchiYuichiro DokiPublished in: International journal of clinical oncology (2022)
This is the first report of Japanese patients with gastrointestinal stromal tumors treated with regorafenib. Regorafenib showed efficacy and a manageable safety profile in Japanese patients with advanced gastrointestinal stromal tumors, which was comparable with previous studies.
Keyphrases